You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 17, 2025

Drug Price Trends for FT AD ALLERGY (LORAT)


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for FT AD ALLERGY (LORAT)

Average Pharmacy Cost for FT AD ALLERGY (LORAT)

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FT AD ALLERGY (LORAT) 10 MG TB 70677-1053-01 0.05194 EACH 2025-01-22
FT AD ALLERGY (LORAT) 10 MG TB 70677-1053-02 0.05194 EACH 2025-01-22
FT AD ALLERGY (LORAT) 10 MG TB 70677-1053-03 0.05194 EACH 2025-01-22
FT AD ALLERGY (LORAT) 10 MG TB 70677-1053-01 0.05176 EACH 2024-12-18
FT AD ALLERGY (LORAT) 10 MG TB 70677-1053-03 0.05176 EACH 2024-12-18
FT AD ALLERGY (LORAT) 10 MG TB 70677-1053-02 0.05176 EACH 2024-12-18
FT AD ALLERGY (LORAT) 10 MG TB 70677-1053-03 0.04667 EACH 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Loratadine Market Analysis and Price Projections

Overview of the Loratadine Market

The loratadine market, which includes drugs like FT AD ALLERGY (LORAT), is a significant sector within the pharmaceutical industry. This market is driven by the increasing prevalence of allergic conditions globally, attributed to factors such as environmental pollutants and changing lifestyles.

Market Size and Growth

As of 2023, the global loratadine market was valued at approximately USD 163.2 billion, according to The Brainy Insights, and is expected to reach USD 221.4 billion by 2033, growing at a CAGR of 3.1% from 2024 to 2033[1].

However, other reports indicate a slightly different valuation, with the market size estimated at USD 156.34 million in 2023 and projected to reach USD 186.33 million by 2029, growing at a CAGR of 3.14% during the forecast period[2].

Key Drivers of Market Growth

  • Rising Prevalence of Allergic Conditions: The increasing incidence of allergies such as hay fever, allergic rhinitis, and urticaria is a major driver. For instance, the American Academy of Allergy, Asthma & Immunology reported that over 25.7% of people worldwide in the 18–44 age range experienced seasonal allergies in 2021[1].
  • Changing Lifestyles and Environmental Factors: Genetic predispositions, changing lifestyles, and environmental variables contribute to the high illness load, driving the demand for antihistamine drugs like loratadine[1][3].
  • Regulatory and Healthcare Infrastructure: Stringent regulatory standards and well-established healthcare infrastructure, particularly in regions like North America, support the market's growth[2][5].

Geographical Analysis

North America

North America is the largest market for loratadine, holding a significant market share. In 2023, it accounted for 36.5% of the global market revenue. The region's high prevalence of allergies, well-established healthcare system, and presence of major companies in the loratadine production and marketing sectors drive this dominance. The Asthma and Allergy Foundation of America's report highlighted that around 25 major cities in the region fall into the high-risk category for allergic reactions[1][5].

Asia-Pacific

The Asia-Pacific region is anticipated to exhibit a high growth rate, with a CAGR of 3.8% over the forecast period. This growth is driven by expanding awareness of allergic ailments, a growing senior population susceptible to various allergic problems, and the rising prevalence of lifestyle diseases. For example, an Indian study found that allergic rhinitis was prevalent in 11.3% of children aged 6-7 years and 24.4% of children aged 13-14[3].

Europe

Europe holds a moderate share of the market, with the UK's aging population and extended pollen seasons increasing the need for allergy treatment drugs like loratadine. The region's robust healthcare infrastructure and regulatory frameworks also contribute to market growth[3].

Market Segments and Formulations

Dosage Forms

Loratadine is available in various formulations, including tablets, syrup, and orally disintegrating tablets. This versatility contributes to its market prominence and patient compliance[2].

End-Users

The market is segmented based on end-users, with a significant portion being consumers seeking over-the-counter (OTC) medications. The increasing trend of self-medication, especially in regions like the UK, drives the demand for OTC loratadine products[3].

Price Projections and Market Trends

Price Trends

The price of loratadine is expected to remain relatively stable due to the competitive nature of the market and the presence of generic versions. However, innovations in formulations and delivery methods could lead to slight price variations.

Market Trends

  • Increasing Adoption in Emerging Markets: The need for efficient antihistamine drugs like loratadine is rising in emerging nations due to increasing awareness of allergy management and the growth of online pharmacies[1].
  • Research and Development: Ongoing R&D activities aimed at optimizing loratadine formulations and exploring novel delivery methods are expected to enhance the market's growth potential[2][5].
  • Government Initiatives: Increased government efforts to raise allergy awareness, such as the World Allergy Organization's World Allergy Week, are driving market expansion[1][3].

Challenges and Restraints

Side Effects and Alternatives

Despite the market's growth potential, side effects associated with loratadine and the availability of alternative antihistamines can restrain market growth. Continuous development in loratadine drugs is crucial to mitigate these challenges[5].

Key Takeaways

  • The global loratadine market is driven by the increasing prevalence of allergic conditions and changing lifestyles.
  • North America is the largest market for loratadine, followed by significant growth potential in the Asia-Pacific region.
  • The market is expected to grow at a CAGR of 3.1% to 3.7% over the forecast period, depending on the source.
  • Innovations in formulations and government initiatives to raise allergy awareness are key factors driving market growth.
  • Despite growth potential, the market faces challenges from side effects and the availability of alternative antihistamines.

FAQs

What is the current global loratadine market size?

The global loratadine market was valued at approximately USD 163.2 billion in 2023[1].

Which region has the largest share in the global loratadine market?

North America holds the largest market share, accounting for 36.5% of the global market revenue in 2023[1].

What is the fastest-growing segment in the loratadine market?

The Asia-Pacific region is anticipated to exhibit the highest growth rate over the forecast period[3][5].

What are the key drivers of the loratadine market growth?

The key drivers include the rising prevalence of allergic conditions, changing lifestyles, and favorable regulatory landscapes[1][2][3].

What are the potential challenges facing the loratadine market?

Side effects associated with loratadine and the availability of alternative antihistamines are significant challenges[5].

Sources

  1. The Brainy Insights: Loratadine Market Size, Share, Growth & Trends Report, 2033
  2. GIIR: Loratadine Market - Global Industry Size, Share, Trends, Opportunity
  3. Straits Research: Loratadine Market to be Worth USD 219.4 million by 2032
  4. AOCD: The Future of Medicine is in Your Hands
  5. Mordor Intelligence: Loratadine Market - Size, Analysis, Industry Share & Growth

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.